Luke Y C Chen

43PUBLICATIONS
74CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsDeep learningImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 11, 2026
Lamotrigine and other therapy-associated HLH syndromes: a review.

|Jul 27, 2026
Recognising idiopathic plasmacytic lymphadenopathy within the evolving spectrum of idiopathic multicentric Castleman disease.

|May 22, 2026
Treatment of severe refractory immune neutropenia with ruxolitinib: Two cases.

|Apr 02, 2026
Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.

Emily Leung, Nicholas R Fragola, Elliott W Sharp

|Apr 02, 2026
Artificial intelligence, personalized education, and the Dunning-Kruger effect.

Haya Al Bitar, Luke Y C Chen

|Apr 01, 2026
Primary Splenic Classic Hodgkin Lymphoma with Immune Thrombocytopenic Purpura and Extramedullary Hematopoiesis.

Ibrahim Elsharawi, Luke Y C Chen, Shannon Murphy

Pageof 8

Frequent Collaborators

5 joint publications

Mariam Goubran

5 joint publications

David C Fajgenbaum

4 joint publications

Emily Leung

4 joint publications

Ryan J Stubbins